• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 06-10-2025: Press Release

    06-10-2025 | 03:02 pm

    Zydus Lifesciences secured USFDA final approval for Deflazacort oral suspension, for Duchenne Muscular Dystrophy (DMD) treatment. This expands Zydus's offerings, adding to its 424 total approvals, strengthening its pipeline.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited